U.S. flag

An official website of the United States government

NM_000516.7(GNAS):c.602G>A (p.Arg201His) AND McCune-Albright syndrome

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Oct 12, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000017290.14

Allele description [Variation Report for NM_000516.7(GNAS):c.602G>A (p.Arg201His)]

NM_000516.7(GNAS):c.602G>A (p.Arg201His)

Gene:
GNAS:GNAS complex locus [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20q13.32
Genomic location:
Preferred name:
NM_000516.7(GNAS):c.602G>A (p.Arg201His)
HGVS:
  • NC_000020.11:g.58909366G>A
  • NG_016194.2:g.74627G>A
  • NM_000516.7:c.602G>AMANE SELECT
  • NM_001077488.5:c.605G>A
  • NM_001077489.4:c.557G>A
  • NM_001077490.3:c.*463G>A
  • NM_001309840.2:c.425G>A
  • NM_001309861.2:c.425G>A
  • NM_016592.5:c.*508G>A
  • NM_080425.4:c.2531G>A
  • NM_080426.4:c.560G>A
  • NP_000507.1:p.Arg201His
  • NP_000507.1:p.Arg201His
  • NP_001070956.1:p.Arg202His
  • NP_001070957.1:p.Arg186His
  • NP_001296769.1:p.Arg142His
  • NP_001296790.1:p.Arg142His
  • NP_536350.2:p.Arg844His
  • NP_536351.1:p.Arg187His
  • NC_000020.10:g.57484421G>A
  • NM_000516.4:c.602G>A
  • NM_000516.6:c.602G>A
  • P63092:p.Arg201His
Protein change:
R142H; ARG201HIS
Links:
UniProtKB: P63092#VAR_003441; OMIM: 139320.0009; dbSNP: rs121913495
NCBI 1000 Genomes Browser:
rs121913495
Molecular consequence:
  • NM_001077490.3:c.*463G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_016592.5:c.*508G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_000516.7:c.602G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001077488.5:c.605G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001077489.4:c.557G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001309840.2:c.425G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001309861.2:c.425G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_080425.4:c.2531G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_080426.4:c.560G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
McCune-Albright syndrome (MAS)
Synonyms:
Albright's Syndrome; Albright's disease; McCune-Albright syndrome, somatic, mosaic; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0018919; MedGen: C0242292; Orphanet: 562; OMIM: 174800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000037562OMIM
no assertion criteria provided
Pathogenic
(May 23, 2014)
somaticliterature only

PubMed (8)
[See all records that cite these PMIDs]

SCV000246257GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV004176928Clinical Genomics Laboratory, Washington University in St. Louis
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 12, 2023)
somaticclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedliterature only
not providedsomaticnot providednot providednot providednot providednot providednot providedliterature only
not providedsomaticyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM.

N Engl J Med. 1991 Dec 12;325(24):1688-95.

PubMed [citation]
PMID:
1944469

Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Schwindinger WF, Francomano CA, Levine MA.

Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5152-6.

PubMed [citation]
PMID:
1594625
PMCID:
PMC49247
See all PubMed Citations (11)

Details of each submission

From OMIM, SCV000037562.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (8)

Description

In 2 patients with McCune-Albright syndrome (174800), Weinstein et al. (1991) identified an arg201-to-his (R201H) mutation in exon 8 of the GNAS gene in endocrine organs affected in this disorder, such as gonads, adrenal glands, thyroid, and pituitary, as well as tissues not classically involved. In 2 endocrine organs, ovary and adrenal, the highest proportion of mutant alleles was found in regions of abnormal cell proliferation. Weinstein et al. (1991) concluded that somatic mutation of the GNAS gene early in embryogenesis resulted in the mosaic population of normal and mutant-bearing tissues that underlie the clinical manifestations of McCune-Albright syndrome. It remained an open question whether GNAS1 mutations were causally related to the nonendocrine abnormalities in 3 of the patients: chronic liver disease in 1, thymic hyperplasia in 2, gastrointestinal adenomatous polyps in 1, cardiopulmonary disease in 1, and sudden death in 2.

Schwindinger et al. (1992) found a G-to-A transition resulting in the R201H substitution in a patient with McCune-Albright syndrome who had severe bony involvement, characteristic skin lesions, and a history of hyperthyroidism. The mutation was found in a higher proportion of skin cells from affected areas than from unaffected areas. The findings confirmed the Happle (1986) hypothesis that this disorder is due to mosaicism for a postzygotic GNAS1 mutation. The authors noted that arg201 is also the site of ADP-ribosylation by the cholera toxin.

Collins et al. (2003) identified the R201H mutation in thyroid carcinoma from a patient with McCune-Albright syndrome.

In 2 growth hormone (GH; 139250)-secreting pituitary tumors (102200) surgically removed from patients with acromegaly, Landis et al. (1989) identified a somatic mutation in the GNAS1 gene, resulting in an R201H substitution. The mutation resulted in constitutive activation of Gs by inhibiting its GTPase activity and behaved like a dominantly acting oncogene.

Fragoso et al. (2003) identified a heterozygous R201H mutation in adrenal tissue from 2 unrelated patients with ACTH-independent macronodular adrenal hyperplasia (219080). Sato et al. (2014) identified a heterozygous somatic R201H mutation in adrenocortical tumors derived from 4 unrelated patients with ACTH-independent Cushing syndrome. GNAS-positive tumors were smaller (average diameter 31.9 mm) than tumors without GNAS mutations (average diameter 37.7 mm), but additional pathologic findings were not reported.

In 1 of 30 cases of juvenile ovarian granulosa cell tumor, the most common sex cord stromal tumor, Kalfa et al. (2006) detected the R201H mutation of the GNAS gene. Laser microdissection confirmed that the mutation was exclusively localized in the tumoral granulosa cells and was absent in the ovarian stroma.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticnot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000246257.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genomics Laboratory, Washington University in St. Louis, SCV004176928.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The GNAS c.602G>A (p.Arg201His) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in multiple individuals with McCune-Albright syndrome (Pienkowski C et al., PMID: 9343290; Chevalier N et al., PMID: 26321108; Elli FM et al., PMID: 31620168; Román R et al., PMID: 15289771; Lumbroso S et al., PMID: 15126527; Cho EK et al., PMID: 27506760). This variant has been reported in the ClinVar database as a germline pathogenic by multiple submitters (ClinVar ID: 15934). This variant is only observed on 2/152134 alleles in the general population (gnomAD v3.1.2), indicating it is not a common variant. Another variant in the same codon, c.601C>T (p.Arg201Cys), has been reported in multiple affected individuals with McCune-Albright syndrome and is considered pathogenic (Lumbroso S et al., PMID: 15126527; Cho EK et al., PMID: 27506760; ClinVar ID: 15933). The GNAS c.602G>A (p.Arg201His) variant resides within a G-alpha domain, amino acids 41-388, of GNAS that is defined as a critical functional domain (Weinstein LS et al., PMID: 11588148; Tesmer JJ et al., PMID: 9417641). Computational predictors indicate that the variant is damaging, evidence that correlates with impact on GNAS function. Based on an internally developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868), the GNAS c.602G>A (p.Arg201His) variant is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 20, 2024